نتائج البحث

Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer.

• Authors : Jager, Eline C.^1,2 (AUTHOR); van Hemel, Bettien M.^2,3 (AUTHOR); Rutgers, Bea³ (AUTHOR)

• Source: Cancers. Mar2025, Vol. 17 Issue 5, p737. 15p.

تفاصيل العنوان

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

• Source: Clinical and Genetic Studies in Familial Non-Medullary Thyroid CancerChen AY, Jemal A, Ward EM.

تفاصيل العنوان

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

• Authors : National Cancer Institute (NCI)

• Source: Utilization of the Natural History of Medullary Thyroid Carcinoma to Inform Advanced Disease Management

تفاصيل العنوان

Natural History Study of Children and Adults With Medullary Thyroid Cancer

• Source: Longitudinal Assessment and Natural History Study of Children and Adults With MEN2A or MEN2B With or Without Medullary Thyroid Carcinoma

تفاصيل العنوان

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

• Authors : National Cancer Institute (NCI)

• Source: Designing a Decision Aid to Help People With Medullary Thyroid Cancer Make Decisions With Their Doctors

تفاصيل العنوان

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)

• Authors : Eli Lilly and Company

• Source: A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve,

تفاصيل العنوان

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation (LIBRETTO-321)

• Source: A Phase 2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including Rearranged in Transfection (RET) Fusion-Positive Solid Tumors,

تفاصيل العنوان

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) (LIBRETTO-001)

• Authors : Loxo Oncology, Inc.

• Source: A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary

تفاصيل العنوان

Predictive Factors for Medullary Thyroid Cancer Aggressiveness (MYELO)

• Authors : Papavramidis Theodossis, Associate Professor

• Source: Predective Factors for Tumor Aggressiveness in Medullary Thyroid Cancer

تفاصيل العنوان

Diagnosis of Bone Metastasis due to Medullary Thyroid Cancer With 99mTc‐ (V) DMSA SPECT Imaging.

• Authors : Gharepapagh, Esmaeil^1,2 (AUTHOR); Houshyar, Jalil³ (AUTHOR); Mamaghani, Farzad Farajbakhsh⁴ (AUTHOR)

• Source: Clinical Case Reports. Dec2024, Vol. 12 Issue 12, p1-5. 5p.

تفاصيل العنوان